BioSLR LATEST

Volume 6, issue 4 of Lawtext Publishing's Bio-Science Law Review has now been published. Apart from Part II of Margaret Llewelyn's "From GATT to G.A.T.T. - Fifty Years of European Bio-IP" (how the IPKat dislikes the serialisation of articles -- and he's not the only one!), there are two other major features:

* "Biogenerics: a Move Towards Regulation of the Unknown" by Zelda Pickup and Andrew Whitworth (CMS Cameron McKenna), on the European Medicines Agency's guidelines for showing that biogenerics have a similar profile to original biopharmaceutical products;

* "GMO Regulation in Europe: a Primer for Patent Applicants" by London barrister Tim Sampson.

Read and enjoy!
BioSLR LATEST BioSLR LATEST Reviewed by Jeremy on Monday, November 15, 2004 Rating: 5

No comments:

All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.

It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.

Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html

Powered by Blogger.